CNXU.US Conexeu Sciences Inc. Common Stock

Healthcare Biotechnology USA Stocks
2.18 USD
Close of Nov 14, 2026
1.93 18.79
Market cap
USD 67.2M
P/E
-
P/B
11.49x
ROE
-267.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is CNXU.US undervalued?

Graham number

The Graham number of Conexeu Sciences Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Conexeu Sciences Inc. Common Stock fundamental analysis

No fundamental analysis for Conexeu Sciences Inc. Common Stock yet.

Conexeu Sciences Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational p…

Full company profile